A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Name: A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

biliary cancer, bile duct cancer, cancer of the bile duct

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 463709
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.